CellSource Co (TSE:4880) Institutional Ownership: 4.36% (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4880 CellSource Co Ltd TSE:4880
70 GF Score
Price 円320.00
GF Value 円778.93
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is CellSource Co Institutional Ownership?

CellSource Co TSE:4880 +2.24% 70 Institutional Ownership is 4.36% as of Aug. 09, 2026. GuruFocus rates TSE:4880 with a GF Score™ of 70/100 and a GF Value™ of 円778.93 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CellSource Co's institutional ownership is 4.36%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CellSource Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CellSource Co's Float Percentage Of Total Shares Outstanding is 0.00%.

CellSource Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for CellSource Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSource Co Institutional Ownership Chart

CellSource Co Historical Data

The historical data trend for CellSource Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 4.39 4.36 4.44 4.44 4.44 4.47 4.50 4.46 4.48 4.36
TSE:4880
70GF Score
CellSource Co Ltd TSE:4880
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSource Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 4.36% mean?
CellSource Co (TSE:4880) has a Institutional Ownership of 4.36% as of Aug. 09, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on CellSource Co and its competitors.
Is CellSource Co's Institutional Ownership too high?
CellSource Co's current Institutional Ownership is 4.36%. Overall, CellSource Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellSource Co's Institutional Ownership compare to VRTX and REGN?
CellSource Co's Institutional Ownership of 4.36% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on CellSource Co and its competitors. CellSource Co's current Institutional Ownership is 4.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSource Co stock overvalued right now?
Based on GuruFocus' analysis, CellSource Co (TSE:4880) is currently considered Significantly Undervalued. The stock's GF Value™ is 円778.93, compared to a current price of 円320.00 — trading 58.9% below its estimated fair value. The current Institutional Ownership is 4.36%. CellSource Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For CellSource Co (TSE:4880), the current Institutional Ownership is 4.36% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellSource Co (TSE:4880) Overvalued in 2026?

Based on GuruFocus' analysis, CellSource Co stock appears to be undervalued. The current stock price of 円320.00 is trading 58.9% below its estimated GF Value™ of 円778.93. GuruFocus considers CellSource Co to be Significantly Undervalued.

Key valuation signals for TSE:4880:

  • Institutional Ownership: 4.36%
  • GF Value™: 円778.93 vs. price of 円320.00 (58.9% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the TSE:4880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CellSource Co Business Description

Address Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
70GF Score

Get the complete analysis for TSE:4880

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円320.00
Price
円778.93
GF Value